PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-67.89%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-214.64%
Negative gross profit growth while MAXN is at 73.39%. Joel Greenblatt would examine cost competitiveness or demand decline.
25.24%
EBIT growth below 50% of MAXN's 71.83%. Michael Burry would suspect deeper competitive or cost structure issues.
51.95%
Operating income growth at 75-90% of MAXN's 66.50%. Bill Ackman would demand a plan to enhance operating leverage.
51.12%
Net income growth at 50-75% of MAXN's 73.10%. Martin Whitman would question fundamental disadvantages in expenses or demand.
51.26%
EPS growth of 51.26% while MAXN is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
51.26%
Diluted EPS growth at 50-75% of MAXN's 73.09%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.33%
Share change of 0.33% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.33%
Diluted share change of 0.33% while MAXN is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-126.11%
Negative OCF growth while MAXN is at 93.92%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-145.35%
Negative FCF growth while MAXN is at 91.23%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
22.72%
Positive 10Y revenue/share CAGR while MAXN is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-46.40%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-58.19%
Negative 3Y CAGR while MAXN stands at 7.06%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-589.71%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
25.26%
Positive OCF/share growth while MAXN is negative. John Neff might see a comparative advantage in operational cash viability.
-321.17%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-5856.79%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-45.21%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-281.88%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-30.93%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-46.59%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-36.42%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while MAXN stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-20.67%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
6.59%
We show growth while MAXN is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-5.27%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-13.05%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
21.24%
We have some new debt while MAXN reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-14.02%
Our R&D shrinks while MAXN invests at 3.39%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.33%
We expand SG&A while MAXN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.